Mitochondrial diseases in Hong Kong: prevalence, clinical characteristics and genetic landscape

[1]  E. Ruiz-Pesini,et al.  The Genetic Landscape of Mitochondrial Diseases in Spain: A Nationwide Call , 2021, Genes.

[2]  R. Ganetzky,et al.  Mitochondrial Hepatopathies , 2021, Clinical liver disease.

[3]  J. Hurst,et al.  Diagnosing Mitochondrial Disorders Remains Challenging in the Omics Era , 2021, Neurology: Genetics.

[4]  M. Mancuso,et al.  Mitochondrial Syndromes Revisited , 2021, Journal of clinical medicine.

[5]  H. Prokisch,et al.  The Dimensions of Primary Mitochondrial Disorders , 2020, Frontiers in Cell and Developmental Biology.

[6]  F. Scaglia,et al.  Clinical trials in mitochondrial disorders, an update , 2020, Molecular Genetics and Metabolism.

[7]  C. Lam,et al.  Movement disorders associated with thiamine pyrophosphokinase deficiency: Intrafamilial variability in the phenotype , 2020, Clinical Neurology and Neurosurgery.

[8]  K. Itoh,et al.  Prevalence of the mitochondrial 1555 A>G and 1494 C>T mutations in a community-dwelling population in Japan , 2020, Human genome variation.

[9]  J. Rahman,et al.  Moving towards clinical trials for mitochondrial diseases , 2020, Journal of inherited metabolic disease.

[10]  C. Sue,et al.  New diagnostic pathways for mitochondrial disease , 2020 .

[11]  C. La Morgia,et al.  Mitochondrial diseases in adults , 2020, Journal of internal medicine.

[12]  H. Prokisch,et al.  Genetics of mitochondrial diseases: Identifying mutations to help diagnosis , 2020, EBioMedicine.

[13]  R. Rodenburg,et al.  Delineation of molecular findings by whole-exome sequencing for suspected cases of paediatric-onset mitochondrial diseases in the Southern Chinese population , 2020, Human genomics.

[14]  Haishan Jiang,et al.  Advances in drug therapy for mitochondrial diseases. , 2020, Annals of translational medicine.

[15]  A. Olry,et al.  Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database , 2019, European Journal of Human Genetics.

[16]  Y. Chien,et al.  Primary coenzyme Q10 deficiency-7: expanded phenotypic spectrum and a founder mutation in southern Chinese , 2019, npj Genomic Medicine.

[17]  W. Chu,et al.  Clinical whole-exome sequencing reveals a common pathogenic variant in patients with COQ10 deficiency: An underdiagnosed cause of mitochondriopathy. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[18]  Robert W. Taylor,et al.  Recent advances in understanding the molecular genetic basis of mitochondrial disease , 2019, Journal of inherited metabolic disease.

[19]  C. Lam,et al.  Whole-exome sequencing of a quartet family identifies DTYMK mutations in siblings with mitochondrial DNA depletion syndrome. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[20]  P. Chinnery,et al.  First-line genomic diagnosis of mitochondrial disorders , 2018, Nature Reviews Genetics.

[21]  R. Horvath,et al.  Revisiting mitochondrial diagnostic criteria in the new era of genomics , 2017, Genetics in Medicine.

[22]  E. Bartnik,et al.  Nuclear genes involved in mitochondrial diseases caused by instability of mitochondrial DNA , 2018, Journal of Applied Genetics.

[23]  H. Prokisch,et al.  A Guideline for the Diagnosis of Pediatric Mitochondrial Disease: The Value of Muscle and Skin Biopsies in the Genetics Era , 2017, Neuropediatrics.

[24]  Hoon-Chul Kang,et al.  Cause of Death in Children With Mitochondrial Diseases. , 2017, Pediatric neurology.

[25]  C. Srisailapathy,et al.  Genetic Epidemiology of Mitochondrial Pathogenic Variants Causing Nonsyndromic Hearing Loss in a Large Cohort of South Indian Hearing Impaired Individuals , 2016, Annals of human genetics.

[26]  R. Płoski,et al.  New perspective in diagnostics of mitochondrial disorders: two years’ experience with whole-exome sequencing at a national paediatric centre , 2016, Journal of Translational Medicine.

[27]  R. Rodenburg,et al.  Mitochondrial disorders in children: toward development of small‐molecule treatment strategies , 2016, EMBO molecular medicine.

[28]  R. Valdez,et al.  Public Health and Rare Diseases: Oxymoron No More , 2016, Preventing chronic disease.

[29]  D. Turnbull,et al.  Mitochondrial disease: genetics and management , 2015, Journal of Neurology.

[30]  C. Lam,et al.  Novel POLG mutation in a patient with sensory ataxia, neuropathy, ophthalmoparesis and stroke. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[31]  S. Rahman.  Emerging aspects of treatment in mitochondrial disorders , 2015, Journal of Inherited Metabolic Disease.

[32]  Marni J. Falk,et al.  Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society , 2014, Genetics in Medicine.

[33]  G. Enns.  Treatment of Mitochondrial Disorders , 2014, Journal of child neurology.

[34]  K. Au,et al.  A patient with congenital hyperlactataemia and Leigh syndrome: an uncommon mitochondrial variant. , 2013, Hong Kong medical journal = Xianggang yi xue za zhi.

[35]  Marni J. Falk,et al.  Molecular Genetic Testing for Mitochondrial Disease: From One Generation to the Next , 2013, Neurotherapeutics.

[36]  J. Smeitink,et al.  Mitochondrial medicine , 2011, Journal of Inherited Metabolic Disease.

[37]  A. Suomalainen.  Biomarkers for mitochondrial respiratory chain disorders , 2011, Journal of Inherited Metabolic Disease.

[38]  K. Au,et al.  A novel mitochondrial DNA deletion in a Chinese girl with Kearns-Sayre syndrome. , 2009, Hong Kong medical journal = Xianggang yi xue za zhi.

[39]  D. Turnbull,et al.  URINE HETEROPLASMY IS THE BEST PREDICTOR OF CLINICAL OUTCOME IN THE m.3243A>G mtDNA MUTATION , 2009, Neurology.

[40]  M. Koenig.  Presentation and diagnosis of mitochondrial disorders in children. , 2008, Pediatric Neurology.

[41]  R. Sokol,et al.  Mitochondrial hepatopathies: Advances in genetics and pathogenesis , 2007, Hepatology.

[42]  Y. Mak,et al.  Mitochondrial DNA deletion in a girl with Fanconi’s syndrome , 2007, Pediatric Nephrology.

[43]  R. Rodenburg,et al.  Mitochondrial disease criteria , 2006, Neurology.

[44]  R. Naviaux,et al.  POLG mutations associated with Alpers syndrome and mitochondrial DNA depletion , 2005, Annals of neurology.

[45]  J. Belmont,et al.  Clinical Spectrum, Morbidity, and Mortality in 113 Pediatric Patients With Mitochondrial Disease , 2004, Pediatrics.

[46]  D. Thorburn,et al.  Mitochondrial disorders: Prevalence, myths and advances , 2004, Journal of Inherited Metabolic Disease.

[47]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[48]  C. Desnuelle,et al.  [Mitochondrial diseases in adults]. , 2001, La Revue de medecine interne.

[49]  L. Wong,et al.  De novo mutation in the mitochondrial tRNALeu(UUR) gene (A3243G) with rapid segregation resulting in MELAS in the offspring , 2001, Journal of paediatrics and child health.

[50]  J. Williams,et al.  Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) triggered by valproate therapy , 1997, European Journal of Pediatrics.

[51]  A. Schapira,et al.  Mitochondrial disorders: an overview. , 1997, Journal of bioenergetics and biomembranes.

[52]  C. Lam,et al.  Diagnosis of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes in a Chinese family by PCR/restriction enzyme analysis , 1995, Clinical molecular pathology.